Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
Historic Lefferts House Officially Reopens to the Public
The beloved Lefferts Historic House reopened in Prospect Park, as city green space stewards held a ribbon cutting over the weekend for the restored 18th century farmhouse museum.
The reopening came after the museum, jointly operated by the Prospect Park

